As it stands today, first-line treatments for pain management are often associated with adverse systemic effects, including gastrointestinal erosions, constipation, central nervous system depression, addiction, and tolerance. Moreover, many currently available commercial analgesics are limited in therapeutic efficacy, rendering many pain symptoms left untreated or inadequately managed. With compounded topical creams and gels, patients are better able to target the site of action through local application to affected regions, limiting systemic reactions and in many cases, improving therapeutic outcome. In addition, compounders can develop low-dose multi-drug formulations that reach multiple nociceptive pathways, further optimizing targeted effect and ultimately therapeutic payoff.
The objective of this laboratory training is to expose pharmacists and technicians to the hands-on experience of compounding dosage forms common to the niche market of analgesic therapy, notably creams, gels, and pastes. Participants will learn how to optimize the efficiency and quality of their compounding process by practicing novel compounding techniques and implementing innovative technologies and equipment.
- Clonidine HCl 0.16%, Gabapentin 6%, Ketamine† HCl 5.75 % Topical Cream
- Diclofenac Sodium 5% Topical Gel
- Capsaicin 0.025%, Lidocaine 6%, Tetracaine 4% Dental Paste
Note: Formulas are subject to change.
†Controlled substances will be replaced by non-controlled substances.
DURATION: 4 HOURS
Tammy Nguyen, BPharm
Compounding Pharmacist, MEDISCA Australia.
Rebecca O’Grady, BPharm, GradCertPharmPrac
Technical Support Services Representative, MEDISCA Australia.
Patricia Ullmann, BPharm
Training and Support Services Manager, MEDISCA Australia.
Activity material is Copyright© 2017-2019 LP3 Network Inc.
Full attendance and participation is required to receive a Certificate of Attainment.
DECLARATIONS AND DISCLOSURES
This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA AUSTRALIA ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense of the activity participant.
FOOD AND BEVERAGE
As a matter of activity programming, meals and refreshments during live activities have been provided by MEDISCA Australia.
CANCELLATION AND REFUND POLICY
In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation. In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date.This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.
TRANSFER POLICY – AUSTRALIA COURSES ONLY
This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.